A Birmingham MedTech has raised £2.25 million and launched a new product range for improved fitting of lower-limb prostheses.

Adapttech, a star of our MedTech 50 ranking last year, said the INSIGHT range is a family of products that make it faster and easier to fit lower-limb prostheses and improve patient outcomes.

The new funding, from investors including Mercia Asset Management, ACF Investors, Wren Capital and Wealth Club, will be used by Adapttech to further develop smart, wearable technologies to help people with physical limitations improve their quality of life. 

The company says it is the first to combine 3D scanning with dynamic pressure data, providing time and cost efficiency benefits to orthotics and prosthetics clinics and their patients.

The company’s flagship product, the INSIGHT system, has today been upgraded into a full product range, with several new options for O&P professionals.

This includes INSIGHT Sense, an affordable, portable, and standalone real-time analysis pressure measurement system targeted at smaller O&P clinics to reduce hardware costs and help them provide house calls to remote patients.

INSIGHT Digitizer is a standalone digitiser for prosthetic sockets that creates high-resolution 3D models and is targeted at central fabrication and large O&P clinic groups.

INSIGHT Pro combines both the INSIGHT Digitiser and INSIGHT Sense and is targeted at larger O&P clinic groups, central fabrication, and research facilities and universities.

“With the new INSIGHT Range, we’re responding to requests for a scanner-less system, reduced hardware costs, and improved data collection,” said Frederico Carpinteiro, CEO at Adapttech.

“This new funding comes at a time when we are developing exciting new technologies to benefit our O&P clinic customers and their patients. We look forward to continuing our trajectory in growing our revenues, product portfolio, and international business operations.”

Adapttech recently signed licensing deals with Modus Health for its StepWatch step-count software, the University of Washington for the Prosthetic Limb Users Survey of Mobility (PLUS-M) self-reporting tool, and Advanced Rehabilitation Therapy for the Amputee Mobility Predictors (AMPPro / AMPnoPro). 

These industry measurement tools will be incorporated into future product designs and patient outcome models.

The ‘three Ts’ that drive MedTech success

Stephen Windsor, investment director at Mercia, said: “Adapttech brought its first product to market during 2021, successfully securing a number of sales. 

“We are delighted to be supporting the team with a follow-on investment to continue to scale the business and build out the product portfolio.”